Atopic Dermatitis

Treatment with 13 mg or 30 mg of upadacitinib showed improvement for patients with atopic dermatitis affecting the head and neck regions, according to a poster presented at the European Academy of Dermatology and Venereology Congress.

Zoryve cream 0.15% continues to show that it can provide clinical improvement to patients with atopic dermatitis, according to a press release.

Rocatinlimab exhibited promising results in the phase 3 ROCKET HORIZON trial for the treatment of moderate to severe atopic dermatitis, Kyowa Kirin announced in a press release.

Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.

Children diagnosed with atopic dermatitis or food allergy were more likely to develop either disorder as time went on, according to a study published in Pediatric Allergy and Immunology.

Organon and Dermavant have entered a definitive agreement in which Organon will acquire Dermavant, according to a press release.

Adbry 300 mg/2 mL single-dose autoinjector is now available for the treatment of adults with moderate to severe atopic dermatitis in the U.S., LEO Pharma announced in a press release.

Eli Lilly and Company announced it received FDA approval for Ebglyss for the treatment of moderate-to-severe atopic dermatitis that is not well controlled with topical prescription therapies, according to a company press release.

Researchers confirmed that the interleukin-1 receptor-associated kinase 4 protein plays a role in the pathogenesis of hidradenitis suppurativa and that a degrader treatment may impact the disease, according to a study.

Fish oil supplementation during pregnancy was associated with children having a lower or higher risk for developing atopic dermatitis depending on the mother’s genotype, according to a study.